Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Astrocytoma × Valacyclovir × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Mesothelioma 1 Lung Neoplasms 1 Glioma 1 Glioblastoma 1 Breast Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 31 Radiotherapy 14 Filgrastim 13 Carboplatin 9 Surgical Procedures, Operative 8 O(6)-benzylguanine 8 Carmustine 8 Radiation 7 Irinotecan 7 Granulocyte Colony-Stimulating Factor 7 Flucytosine 7 sargramostim 5 Specimen Handling 5 Radiotherapy, Intensity-Modulated 5 Magnetic Resonance Spectroscopy 5 vocimagene amiretrorepvec 4 Thiotepa 4 Peripheral Blood Stem Cell Transplantation 4 Melphalan 4 Lenalidomide 4 Genetic Therapy 4 Etoposide 4 Erlotinib Hydrochloride 4 Cyclophosphamide 4 Chemotherapy, Adjuvant 4 Busulfan 4 Bevacizumab 4 Topotecan 3 Nivolumab 3 Imatinib Mesylate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00751270 2023-08-25

BrTK01

Candel Therapeutics, Inc.

Phase 1 Completed

Astrocytoma, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡